Advisornet Financial’s Royalty Pharma RPRX Stock Holding History

Advisornet Financial's RPRX Position: Q2 2026 in Review

Advisornet Financial increased its Royalty Pharma (RPRX) stake by 11% in Q2 2026, buying an estimated $208 and bringing the position to 41 shares worth $2.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

Advisornet Financial first reported a position in RPRX in Q4 2023 and has held it in 7 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

• Advisornet Financial held 41 shares of Royalty Pharma worth $2.3K as of Q2 2026.
• Advisornet Financial bought 4 Royalty Pharma shares in Q2 2026, an estimated $208.
• Royalty Pharma made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1906 holding.
• Advisornet Financial first reported a position in Royalty Pharma in Q4 2023 and has held it in 7 quarters since.
• 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.